Cite
Effect of Pegcetacoplan on quality of life in patients with Paroxysmal Nocturnal Hemoglobinuria : Week 48 of PEGASUS phase 3 trial comparing Pegcetacoplan to Eculizumab
MLA
Panse, J., et al. Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria : Week 48 of PEGASUS Phase 3 Trial Comparing Pegcetacoplan to Eculizumab. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.unidue...bib..0b2a28e9b910d8e1f1eb715513411d17&authtype=sso&custid=ns315887.
APA
Panse, J., Höchsmann, B., Griffin, M., De Castro, C. M., Szer, J., Usuki, K., Soret, J., Al-Adhami, M., Chen, C., Sarda, S. P., & Röth, A. (2021). Effect of Pegcetacoplan on quality of life in patients with Paroxysmal Nocturnal Hemoglobinuria : Week 48 of PEGASUS phase 3 trial comparing Pegcetacoplan to Eculizumab.
Chicago
Panse, J., B. Höchsmann, M. Griffin, C. M. De Castro, J. Szer, K. Usuki, J. Soret, et al. 2021. “Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria : Week 48 of PEGASUS Phase 3 Trial Comparing Pegcetacoplan to Eculizumab,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.unidue...bib..0b2a28e9b910d8e1f1eb715513411d17&authtype=sso&custid=ns315887.